Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupUrologic OncologyDiseasePenile CarcinomaSubgroupICD10C60.-MeSHPenile NeoplasmsUrethral NeoplasmsSequenceChemotherapyChemo-substanceCisplatinFluorouracilIfosfamidePaclitaxelChemo-substanceCisplatinFluorouracilIfosfamidePaclitaxelChemo-substanceCisplatinFluorouracilIfosfamidePaclitaxelChemo-substanceCisplatinFluorouracilIfosfamidePaclitaxelNo. Substances123 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronMagnesiumMagnesium sulfateMesnaPegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronMagnesiumMagnesium sulfateMesnaPegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronMagnesiumMagnesium sulfateMesnaPegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCimetidineDexamethasoneDimetindenFosaprepitantGranisetronMagnesiumMagnesium sulfateMesnaPegfilgrastimPotassium chlorideNo. Substances57910Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationRelapse therapyTherapy phaseneoadjuvantneoadjuvant / adjuvantTherapy intentioncurativepalliativeRisksAllergic ReactionAnemia Hb below 8g/dlCardiotoxicityConstipationDiarrheaEmetogenicity (MASCC/ESMO)Febrile NeutropeniaHyperglycemiaInfectionsMucositisNeuropathyNeutropeniaRenal FailureThrombocytopenia below 50 000/µlThromboembolic Event only studiesPublicationAuthorDi Lorenzo GHussein APagliaro LPizzocarro GDiseasePatienten mit primär nicht resektablen Lymphnotenmetastasen oder Rezidiv der LymphknotenmetastasenPenis-Ca, vortherapiert mit CisplatinPeniskarzinom im Stadium cTx, cN2/N3, cM0, ECOG 0-2, neoadjuvante TherapieRezidiviertes oder nicht-resezierbares Penis-/UrethrakarzinomOriginDepartment of Genitourinary Medical Oncology, The University of Texas, Houston, TexasGenitourinary Oncology and Rare Cancer Center, Federico II University, Naples, ItalySylvester Comprehensive Cancer Center, University of Miami School of Medicine, FloridaUrologic Clinic 2nd, S. Giuseppe Hospital, Milan University, Milan, ItalyProtocols in Revision 4 protocols foundProtocols under revision.Cisplatin 100 / Fluorouracil 960, Penile Carcinoma (PID1443)Paclitaxel 120 / Cisplatin 50 / Fluorouracil 1000, Penile Carcinoma (PID1442)Paclitaxel 175, Penile Carcinoma (PID1648)TIP (Paclitaxel 175 / Ifosfamide 1.2 / Cisplatin 25), Penile Carcinoma, neoadjuvant / adjuvant. (PID1444)
